Search - tctmd.com

Displaying 561 - 580 of 806

Sort: Relevancy | Date

Presentation TCT 2014

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Presenter: Georgios Vlachojannis

September 16, 2014

Presentation TCT 2014

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

Presenter: Kazuyuki Yahagi

September 16, 2014

Presentation TCT 2014

Choice of Metallic DES Stents for Bifurcation Stenting

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Francesco Burzotta

September 15, 2014

Presentation TCT 2014

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Presenter: Evald H. Christiansen

September 14, 2014

Presentation TCT 2014

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi, Lisette Okkels Jensen

September 14, 2014

Presentation TCT 2014

Focal Treatment of Vulnerable Plaque: Stents, Scaffolds, and Prospect ABSORB

Presenter: Valentin Fuster, Patrick W. Serruys, Gregg W. Stone

September 14, 2014

Presentation TCT 2014

Case #4: My Preferred Technique When 2 Stents are Needed DK Crush

Presenter: Jean Fajadet, Marie-Claude Morice, Seung-Jung Park, Corrado Tamburino, Shao Liang Chen

September 14, 2014

Presentation TCT 2014

Case #3: My Preferred Technique When 2 Stents are Needed - Culotte

Presenter: Jean Fajadet, Marie-Claude Morice, Seung-Jung Park, Corrado Tamburino

September 14, 2014

Presentation TCT 2014

Case #2: My Preferred Technique When 2 Stents are Needed - T or TAP

Presenter: Jean Fajadet, Marie-Claude Morice, Seung-Jung Park, Corrado Tamburino

September 14, 2014

Presentation TCT 2014

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Presenter: Gregg W. Stone, Pieter C. Smits, Fernando Alfonso

September 14, 2014

Presentation TCT 2014

Multilayer Stents for the Treatment of Visceral Aneurysms: Hope or Hoax?

Presenter: John R. Laird Jr, Daniel J. McCormick, Dmitriy N. Feldman, Michel Camille Henry

September 13, 2014

Presentation TCT 2014

Covered Stents for Iliac and SFA Obstructive Disease: Overhyped or Underused?

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon

September 13, 2014

Presentation TCT 2014

Next-Generation Carotid Artery Stents: Are Mesh/Membrane Stents Game Changers?

Presenter: Leo Nelson Hopkins, Sriram S. Iyer, Zvonimir Krajcer, Peter A. Schneider

September 13, 2014

Presentation TCT 2014

Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

Presenter: Emmanouil S. Brilakis, J. Dawn Abbott

September 13, 2014

Presentation ESC 2014

SCAAR: Lower late and very late stent thrombosis rates with new generation drug eluting stents compared to bare metal stents

Presenter: Christoph Varenhorst

August 30, 2014

Presentation

Invasive Management Without Stents in Selected ACS Patients with a Large Thrombus Burden: A Prospective Study of OCT-Guided Treatment Decisions

Presenter: Geraud Souteyrand

July 30, 2014

Presentation

Usefulness of Postmarket Studies to Evaluate Long-term Safety of Coronary Stents

Presenter: Moshe Vardi

June 11, 2014

Presentation EuroPCR 2014

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Presenter: Stephan Windecker

May 22, 2014

Presentation EuroPCR 2014

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Presenter: Hiroyoshi Yokoi

May 21, 2014

Presentation Fellows 2014

Drug-Eluting Stents: Past, Present, and Future

Presenter: Gregg Stone

April 12, 2014

Advertisement

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

Choice of Metallic DES Stents for Bifurcation Stenting

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Focal Treatment of Vulnerable Plaque: Stents, Scaffolds, and Prospect ABSORB

Case #4: My Preferred Technique When 2 Stents are Needed DK Crush

Case #3: My Preferred Technique When 2 Stents are Needed - Culotte

Case #2: My Preferred Technique When 2 Stents are Needed - T or TAP

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Multilayer Stents for the Treatment of Visceral Aneurysms: Hope or Hoax?

Covered Stents for Iliac and SFA Obstructive Disease: Overhyped or Underused?

Next-Generation Carotid Artery Stents: Are Mesh/Membrane Stents Game Changers?

Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

SCAAR: Lower late and very late stent thrombosis rates with new generation drug eluting stents compared to bare metal stents

Invasive Management Without Stents in Selected ACS Patients with a Large Thrombus Burden: A Prospective Study of OCT-Guided Treatment Decisions

Usefulness of Postmarket Studies to Evaluate Long-term Safety of Coronary Stents

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Drug-Eluting Stents: Past, Present, and Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content